Dynapenia could predict chemotherapy-induced dose-limiting neurotoxicity in digestive cancer patients

MLA

Barbara Tailliere, et al. “Dynapenia Could Predict Chemotherapy-Induced Dose-Limiting Neurotoxicity in Digestive Cancer Patients.” BMC Cancer, vol. 18, no. 1, Oct. 2018, pp. 1–9. EBSCOhost, https://doi.org/10.1186/s12885-018-4860-1.

APA

Barbara Tailliere, Damien Botsen, Florian Slimano, Johanna Moreau, Yohann Renard, Coralie Barbe, Mathilde Brasseur, Camille Mazza, Marine Perrier, Marie-Amélie Ordan, Eric Bertin, & Olivier Bouché. (2018). Dynapenia could predict chemotherapy-induced dose-limiting neurotoxicity in digestive cancer patients. BMC Cancer, 18(1), 1–9. https://doi.org/10.1186/s12885-018-4860-1

Chicago

Barbara Tailliere, Damien Botsen, Florian Slimano, Johanna Moreau, Yohann Renard, Coralie Barbe, Mathilde Brasseur, et al. 2018. “Dynapenia Could Predict Chemotherapy-Induced Dose-Limiting Neurotoxicity in Digestive Cancer Patients.” BMC Cancer 18 (1): 1–9. doi:10.1186/s12885-018-4860-1.